Probiotics in Functional Dyspepsia

Study acronym: ProPepsis
StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Completed without a posted recruiting period Show 5 more changesShow less
    • Primary completion date changed from estimate of Mar 1, 2026 to May 1, 2026
    • Study sites: 0 to 1
    • Study completion date changed from estimate of May 1, 2026 to May 23, 2026
    • Start date changed from estimate of Jan 5, 2026 to Jan 15, 2026
    • Eligibility criteria expanded, about 22 words
  2. Notable Start date: Dec 1, 2025 to Jan 5, 2026v2
  3. Minor Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to learn whether a multi-strain probiotic can reduce digestive symptoms and improve quality of life in adults with functional dyspepsia. The main questions it aims to answer are: * Does the probiotic reduce symptoms such as fullness after meals, bloating, stomach discomfort, and early satiation? * Does the probiotic improve emotional well-being, including stress, anxiety, and mood? Researchers will compare the probiotic to a placebo (a look-alike capsule with no active ingredients) to see if the probiotic truly helps adults with functional dyspepsia. Participants will: * Take one capsule of the probiotic or placebo once daily before meals for 60 days * Complete questionnaires about their digestive symptoms at the start, 1 month, and 2 months * Complete surveys on stress, anxiety, depression, and quality of life at the start and 2 months * Attend scheduled study visits for checkups and assessments
Trial Details
NCT Number NCT07276009
Lead Sponsor Nordic Biotic Sp. z o.o.
Conditions
(from sponsor)
Functional Dyspepsia
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov